VALYSTR · Stock research
Listed on NasdaqCM. What the market is pricing into Niagen Bioscience, Inc. (NAGE) in the Healthcare sector: implied growth, valuation scenarios, SEC-filed financials, and what has moved the stock.
Healthcare · Medicinal Chemicals & Botanical Products · market value about $188M · P/E 13.1 · revenue $129M (as of 2026-11-04)
Opening the full page… All companies · Research guides · What a reverse DCF shows